Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Brexit tussle bogs down UK midcaps

Published 23/10/2019, 17:35
© Reuters. Traders are seen at work at Northern Trust offices in London

By Muvija M and Shashwat Awasthi

(Reuters) - Shares in domestically-focussed UK companies slid on Wednesday while those on the blue-chip FTSE 100 inched higher as votes in parliament kept investors guessing on the final timing and shape of Britain's withdrawal from the European Union.

With worries over turbulence in Hong Kong and global growth feeding losses for stock markets globally, the FTSE 250 index of midcap firms (FTMC) dipped 0.4% by 0745 GMT.

Helped by a dip for the pound

Precious metals miner Fresnillo (L:FRES) dropped nearly 2% after it forecast annual silver and gold production at the lower end of an already reduced target range, and reported a fall in quarterly output.

While lawmakers voted for a second hearing on the departure agreement, rejection of Johnson's timetable raises the likelihood of another delay in Britain's withdrawal as well as the prospect of a snap election before Christmas.

"The latest twist in the Brexit saga also means that investors may have to contend with more political risk by way of a UK election," said Han Tan, Market Analyst at FXTM.

Raymond James analyst Chris Bailey called the Brexit situation "a mess" overall and said the core scenario of an extension or an election was becoming more likely.

The uncertainty around Brexit and its consequences continues to show up in the performance of UK firms. Housebuilders (FTNMX3720), considered among the most vulnerable, lost nearly 1%, with Barratt (L:BDEV), Persimmon (L:PSN) and Berkeley (L:BKGH) the biggest losers on the blue chip index.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

That was offset by gains for companies who earn largely in foreign currencies including British American Tobacco (L:BATS) and pharmaceutical giant GlaxoSmithKline (L:GSK).

Miner Centamin (L:CEY) also shone on the FTSE 250 with a 3% gain after third-quarter production report.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.